Researchers conclude that chemotherapy is associated with a greater than six-month improvement in median survival among elderly patients with small-cell lung cancer, even in patients over the age of 80 years.
Researchers conclude that chemotherapy is associated with a greater than six-month improvement in median survival among elderly patients with small-cell lung cancer, even in patients over the age of 80 years.